StageZero Life Sciences LtdOTCQB:SZLSFView on Canadian Exchange
- LAST PRICE0.0400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0128/ 100
- Ask / Lots0.0400/ 468
- Open / Previous Close0.0000 / 0.0400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | SZLSF |
|---|
Apr 9, 2024
Canadian Investment Regulatory Organization Trading Halt - SZLS, from 8:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 5, 2024
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order, from 7:55AM ET on Friday Apr 05, 2024 by Dow Jones
7:55AM ET on Friday Apr 05, 2024 by Dow Jones
Apr 2, 2024
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results, from 9:33PM ET on Tuesday Apr 02, 2024 by Dow Jones
9:33PM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
StageZero Life Sciences Ltd | 4.9M | 0.0x | --- |
Company Information
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.
Contact Information
- Headquarters
- 30-70 East Beaver Creek RoadRICHMOND HILL, ON, Canada L4B 3B2
- Phone
- 905-209-2030
- Fax
- 905-209-2030
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9M |
|---|---|
Revenue (TTM) | $4.1M |
Shares Outstanding | 123.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $-0.16 |
Book Value | $-0.10 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -418.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
